Swiss drugmakers face mixed fortunes amid Trump tariffs
Smaller pharma companies will likely be more impacted by US tariffs on patented drugs than bigger companies. Keystone…
How pharma became Switzerland’s Achilles heel in US trade talks
Drug prices are at least 2.5 times higher in the US. Keystone-SDA Listen to the article Listening the…